Roche Diagnostics Corporation Factor Xiiia (Ep3372) Pab, Cell Marque

Roche Diagnostics Corporation factor xiiia (ep3372); factor xiiia is a blood proenzyme that has been identified in platelets, megakaryocyte, and fibroblast-like mesenchymal or histiocytic cells present in the placenta, uterus, and prostate; it is also present in monocytes and macrophages and dermal dendritic cells. anti- factor xiiia has been found to be useful in differentiating between dermatofibroma (9% (+)), dermatofibrosarcoma protuberans (25%(+)) and desmoplastic malignant melanoma (%(+)). factor xiiia positivity is also seen in capillary hemagioblastoma (1%(+)), hemangioendothelioma (1%(+)), hemangiopericytoma (1%(+)), xanthogranuloma (1%(+)), xanthoma (1(+)), hepatocellular carcinoma (93%(+)), glomus tumor (8%(+)), and meningioma (8 % (+)). - ROCHMSD (Additional S&H or Hazmat Fees May Apply)